Catalyst
Slingshot members are tracking this event:
Allergran (AGN) and Paratek (PRTK) expecting approval for Sarecycline, an antibiotic designed to treat inflammatory acne
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 03, 2018
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=253770&p=irol-newsArticle&ID=2369833
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Inflammatory Acne, Fda Approval
